GE

Gabriela Ecco

Senior Associate at +ND Capital

Lausanne, Vaud

Invests in

Locations:

  • Min Investment:

    $100,000.00
  • Max Investment:

    $5,000,000.00
  • Target Investment:

    $1,500,000.00

Education

Work Experience

  • Board Observer

    2023

  • Senior Associate

    2023

  • Associate

    2021 - 2022

  • Innovation Fellow

    2021 - 2021

2022

  • Board Observer

    2022

Osasuna Therapeutics

2022

  • Board Observer

    2022

  • Board Observer

    2021

EVIR Therapeutics

2021

  • Board Observer

    2021

2021 - 2022

  • Board Observer

    2021 - 2022

2016 - 2021

  • Genomics Research Expert

    2020 - 2021

    - Led different R&D projects to develop next generation sequencing (NGS) products for precision medicine and molecular diagnostics in oncology.

  • Senior NGS Scientist

    2019 - 2020

    - Led different R&D projects to develop next generation sequencing (NGS) products for precision medicine and molecular diagnostics in oncology.

  • NGS Scientist

    2016 - 2019

    - Coordinated and participated in different projects to develop products for precision medicine and molecular diagnostics in oncology. - Performed on-site customer trainings in Europe and South America and provided internal and external technical support.

  • Research Assistant

    2011 - 2016

    Development of a large-scale functional screen to determine the function of KRAB-ZFP transcription factors, and biological validation of candidates in early embryogenesis and in somatic tissues (PhD advisor: Prof Didier Trono).

  • Summer Intern

    2015 - 2015

    Evaluated the effects of hydrogels in cartilage tissue engineering at Prof Tsuyoshi Takato laboratory.